// App-Quantinova.ai

: Calibrated CAR Activation Potential Directs Alternative T Cell Fates and Therapeutic Potency

Researchers

Presenter

  • Judith Feucht

Principal Investigators

  • Jie Sun

  • Justin Eyquem

  • Yu-Jui Ho

  • Zeguo Zhao

  • Josef Leibold

  • Anton Dobrin

  • Annalisa Cabriolu

  • Mohamad Hamieh

  • Michel Sadelain

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Institute of Hematology, Zhejiang University & Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Zhejing, China

  • Center for Cell Engineering and Immunology Program, Memorial Sloan Kettering Cancer Center, New York City, NY

  • Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY.

  • Louis V. Gerstner Sloan Kettering Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY

Locations

  • United States

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Hematological malignancies

Biomarkers

  • Coxsackie Virus And Adenovirus Receptor

  • T-cell receptor

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved